Search

everythinglearnresearchcommunity

for

Search:↓

Inherited ichthyoses cause widespread skin scaling and thickening due to gene mutations.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

SHBG may be a useful early indicator and treatment target for PCOS.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Changes in keratin affect skin health and can lead to skin disorders like blistering diseases and psoriasis.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Hormones and genes affect hair growth and male baldness.

Hair can indicate early signs of metabolic disorders, with issues like protein deficiency stopping hair growth.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

A woman with acromegaloidism and normal growth hormone levels had a rare X-Tetrasomy, suggesting a need to study X-chromosome genes for their role in growth and facial development.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.